New Delhi: Morepen Laboratories Limited has received U. S. Food and drug Administration (USFDA) approval for its anti-allergy drug Fexofinadine Hydrochloride that is marketed in India under the.
NEW DELHI, Dec 3: Drug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofinadine Hydrochloride in the American market. The company sells the product in India under the brand name Allegra. Morepen’s product is the generic version of Sanofi Aventis’ anti- allergy drug. Fexofinadine is the most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever. In a statement, the company said […]
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.